Efficacy of pulmonary surfactant with budesonide in infants born at or less than 28 weeks’ gestation: a systematic review and meta-analysis
Abstract Pulmonary surfactant (PS) is the standard treatment for respiratory distress syndrome in preterm infants. Budesonide, a corticosteroid with anti-inflammatory properties, has been studied for use with PS to potentially improve respiratory outcomes and reduce bronchopulmonary dysplasia (BPD)...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2025-12-01
|
| Серии: | Scientific Reports |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1038/s41598-025-33028-0 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|